Oral DehydraTECH-liraglutide showed a pronounced reduction in adverse events (“AEs”) as compared to injected liraglutide (Saxenda®) Lexaria has now demonstrated, in distinct human clinical studies, clear reductions in AEs utilizing its patented DehydraTECH technology with all of the three major GLP-1 drugs sold in the world today: liraglutide, semaglutide and tirzepatide
Oral DehydraTECH-liraglutide showed a pronounced reduction in adverse events (“AEs”) as compared to injected liraglutide (Saxenda(R)) Lexaria has now demonstrated, in distinct human clinical studies, clear reductions in AEs utilizing its patented DehydraTECH technology with all of the three major GLP-1 drugs sold in the world today: liraglutide, semaglutide and tirzepatide KELOWNA, BC / ACCESS Newswire / June 11, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce that human study GLP-1-H25-5 (the "Study") which compared oral capsules of DehydraTECH-liraglutide to injected Saxenda®-branded liraglutide has been successfully completed with partial results now available. In distinct clinical human studies, Lexaria has now demonstrated clear reductions in AEs utilizing oral DehydraTECH versions of all three of the major GLP-1 drugs sold in the world today: liraglutide, semaglutide, and tirzepatide.
Omada Health is making its public-market debut, propelled by Americans' renewed focus on how weight affects physical health.
![]() GLP In 1 month Estimated | Quarterly | $0.74 Per Share |
![]() GLP 1 month ago Paid | Quarterly | $0.74 Per Share |
![]() GLP 4 months ago Paid | Quarterly | $0.74 Per Share |
![]() GLP 7 months ago Paid | Quarterly | $0.73 Per Share |
![]() GLP 10 months ago Paid | Quarterly | $0.72 Per Share |
![]() GLP 8 May 2024 Paid | Quarterly | $0.71 Per Share |
6 May 2025 Date | | - Cons. EPS | 0.36 EPS |
26 Feb 2025 Date | | 0.24 Cons. EPS | 0.52 EPS |
8 Nov 2024 Date | | 1.57 Cons. EPS | 1.17 EPS |
7 Nov 2024 Date | | 1.57 Cons. EPS | - EPS |
7 Aug 2024 Date | | 1.5 Cons. EPS | 1.1 EPS |
![]() GLP In 1 month Estimated | Quarterly | $0.74 Per Share |
![]() GLP 1 month ago Paid | Quarterly | $0.74 Per Share |
![]() GLP 4 months ago Paid | Quarterly | $0.74 Per Share |
![]() GLP 7 months ago Paid | Quarterly | $0.73 Per Share |
![]() GLP 10 months ago Paid | Quarterly | $0.72 Per Share |
![]() GLP 8 May 2024 Paid | Quarterly | $0.71 Per Share |
6 May 2025 Date | | - Cons. EPS | 0.36 EPS |
26 Feb 2025 Date | | 0.24 Cons. EPS | 0.52 EPS |
8 Nov 2024 Date | | 1.57 Cons. EPS | 1.17 EPS |
7 Nov 2024 Date | | 1.57 Cons. EPS | - EPS |
7 Aug 2024 Date | | 1.5 Cons. EPS | 1.1 EPS |
Oil & Gas Midstream Industry | Energy Sector | Mr. Eric S. Slifka CEO | NYSE Exchange | 37946R109 Cusip |
US Country | 3,300 Employees | 9 May 2025 Last Dividend | - Last Split | 29 Sep 2005 IPO Date |
Global Partners LP is a diverse energy supply company established in 2005, headquartered in Waltham, Massachusetts. The company's core operations encompass the purchase, sale, aggregation, blending, storage, and logistics management of a wide range of petroleum products and renewable fuels. It operates through three primary segments: Wholesale, Gasoline Distribution and Station Operations, and Commercial. By leveraging a comprehensive network of railcars, barges, trucks, and pipelines, Global Partners LP ensures the efficient transportation and delivery of its products to a broad spectrum of wholesalers, retailers, and commercial customers across various sectors.
In its Wholesale segment, the company focuses on the distribution of home heating oil, both branded and unbranded gasoline and gasoline blendstocks, diesel, kerosene, and residual oil. It targets home heating oil and propane retailers along with wholesale distributors. The transportation of these products is facilitated through an extensive network of railcars, barges, trucks, and pipelines, ensuring timely and safe delivery.
Through the Gasoline Distribution and Station Operations segment, Global Partners LP engages in the sale of branded and unbranded gasoline to operators of gasoline stations and sub-jobbers. It also manages gasoline stations and convenience stores, offering a range of services including car wash, lottery, and ATM facilities. Additionally, the company’s operations include the leasing of gasoline stations to third parties.
The Commercial segment of the business caters to a diverse clientele including public sector entities, commercial industries, and industrial end-users. It supplies unbranded gasoline, home heating oil, diesel, kerosene, residual oil, and bunker fuel. Global Partners LP is also known for selling custom blended fuels tailored to specific customer requirements. This segment underscores the company’s ability to meet the specialized needs of its commercial and industrial customers.
Besides its main trading activities, Global Partners LP is significantly involved in the transportation sector, specifically in the movement of petroleum products and renewable fuels. Leveraging rail transportation, the company facilitates the efficient movement of these products from the mid-continent region of the United States and Canada, highlighting its logistical capabilities and commitment to ensuring a steady supply of energy resources.